Gilde Healthcare, the Netherlands-based private equity firm dedicated to the healthcare sector, has held a first and final close on its second healthcare services fund on €100 million.
The lower mid-market Gilde Healthcare Services II will support the growth of healthcare service companies in Benelux and Germany, according to a statement from the firm.
The vehicle’s predecessor closed on €53 million in 2010. Investments from that fund include back pain specialist Fysius, and Stepping Stones, a private nursing home operator specialising in healthcare and residential services for elderly patients with Alzheimer’s disease and related conditions.
Gilde Healthcare Services managing partner Jasper van Gorp said the vehicle drew the backing of “a strong base of blue chip investors”.
According to the firm, Gilde Healthcare Services is currently working on “a number of new investment opportunities” based on its strategy of investing in lower mid-market healthcare services companies with revenues between €7.5 million and €75 million. On January 1st 2015 the firm strengthened its team through the hire of Matteo Racca as investment manager.
This is Gilde Healthcare’s fifth investment fund. Gilde Healthcare Services funds I and II focus on healthcare service providers, including specialist clinics, elderly care and medical product suppliers in Benelux and Germany, while Gilde Healthcare I, II and III target companies developing medicines, medical devices and home and digital health solutions in Europe and the US.
Gilde Healthcare III closed on its €145 million target in November 2013, having held a first close on just under €100 million in the beginning of 2012, PEI reported previously. Investments from this vehicle include Inova Labs, Iwalk and Definiens. Portfolio company Sapiens Steering Brain Stimulation was acquired by Medtronic in August 2014 for $200 million in cash.